Ckd Bio (063160) — Cash Flow Reinvestment Rate

Latest as of June 2026: 1.29x

Ckd Bio (063160) has a Cash Flow Reinvestment Rate of 1.29x as of June 2026, reinvesting ₩3.37 Billion (capex ₩3.37 Billion ) from operating cash flow of ₩2.62 Billion. See Ckd Bio (063160) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.29x
(Capex + Investments) / Operating CF

Total Reinvested

₩3.37 Billion
Capex + Investments

Operating Cash Flow

₩2.62 Billion
KRW

Capital Expenditures

₩3.37 Billion
KRW

Ckd Bio Cash Flow Reinvestment Rate (2008–2024)

Historical reinvestment intensity for Ckd Bio across 14 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Ckd Bio.

Annual Cash Flow Reinvestment Rate for Ckd Bio (2008–2024)

Year-by-year capital reinvestment analysis for Ckd Bio. See 063160 financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2024 0.64x ₩9.04 Billion ₩14.03 Billion ₩4.28 Billion ▼ -95.0%
2020 12.78x ₩61.66 Billion ₩4.82 Billion ₩61.66 Billion ▲ +316.7%
2019 3.07x ₩52.12 Billion ₩16.99 Billion ₩47.31 Billion ▲ +173.3%
2018 1.12x ₩17.44 Billion ₩15.54 Billion ₩16.40 Billion ▲ +2.8%
2017 1.09x ₩22.32 Billion ₩20.45 Billion ₩9.67 Billion ▼ -22.6%
2016 1.41x ₩21.86 Billion ₩15.50 Billion ₩10.76 Billion ▲ +68.8%
2015 0.84x ₩11.98 Billion ₩14.34 Billion ₩11.91 Billion ▲ +174.2%
2014 0.30x ₩3.42 Billion ₩11.22 Billion ₩2.87 Billion ▼ -28.4%
2013 0.43x ₩4.65 Billion ₩10.92 Billion ₩4.10 Billion ▲ +30.8%
2012 0.33x ₩7.45 Billion ₩22.90 Billion ₩5.48 Billion ▼ -81.4%
2011 1.75x ₩22.68 Billion ₩12.96 Billion ₩22.09 Billion ▲ +106.3%
2010 0.85x ₩20.26 Billion ₩23.89 Billion ₩19.74 Billion ▲ +64.2%
2009 0.52x ₩13.72 Billion ₩26.57 Billion ₩13.53 Billion ▼ -25.5%
2008 0.69x ₩7.41 Billion ₩10.69 Billion ₩3.47 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow